SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-20-034575
Filing Date
2020-11-02
Accepted
2020-11-02 17:17:56
Documents
11
Effectiveness Date
2020-11-02

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ea129256-defa14a_ziopharm.htm DEFA14A 16453
2 GRAPHIC image_004.jpg GRAPHIC 195011
3 GRAPHIC image_005.jpg GRAPHIC 1284581
4 GRAPHIC image_006.jpg GRAPHIC 125514
5 GRAPHIC image_008.jpg GRAPHIC 75104
6 GRAPHIC image_009.jpg GRAPHIC 249057
7 GRAPHIC image_010.jpg GRAPHIC 463795
8 GRAPHIC image_011.jpg GRAPHIC 330173
9 GRAPHIC image_012.jpg GRAPHIC 596224
10 GRAPHIC image_013.jpg GRAPHIC 168800
11 GRAPHIC image_014.jpg GRAPHIC 145020
  Complete submission text file 0001213900-20-034575.txt   5021436
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33038 | Film No.: 201281304
SIC: 2834 Pharmaceutical Preparations